These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12670780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G, D'Orazio N, Di Ilio C, Della Vecchia R, De Lorenzo A.
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [Abstract] [Full Text] [Related]

  • 3. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V, Ramesh P, Lodha R, Pandey RM, Kabra SK.
    J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E, Gencer M, Aksoy S.
    Respiration; 2004 Oct; 71(6):594-601. PubMed ID: 15627870
    [Abstract] [Full Text] [Related]

  • 7. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M, Piacentini GL, Capasso M, Capristo C, Maiello N, Boner AL, Capristo AF.
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
    Stelmach I, Bobrowska-Korzeniowska M, Majak P, Stelmach W, Kuna P.
    Pulm Pharmacol Ther; 2005 Aug; 18(5):374-80. PubMed ID: 15939317
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR, Sharples LD, Solanki RN, Shah KV.
    Respiration; 2006 Aug; 73(4):449-56. PubMed ID: 16407639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ.
    Am J Respir Crit Care Med; 2003 May 01; 167(9):1232-8. PubMed ID: 12456382
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE, Villa JR, Lee BW, Teper AM, Lyttle B, Aristizabal G, Laessig W, Schuster A, Perez-Frias J, Sekerel BE, Menten J, Leff JA.
    J Pediatr; 2001 May 01; 138(5):694-8. PubMed ID: 11343045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.